27
Participants
Start Date
January 9, 2023
Primary Completion Date
January 9, 2023
Study Completion Date
September 30, 2024
Effects of increased blood flow during regional anticoagulation with 4% trisodium citrate in patients undergoing continuous venovenous hemodiafiltration
"Patients will be exposed to continuous venovenous renal therapy with distinct blood flows in 2 periods, to be defined by draw. The control group will have a flow of 150ml/min and the intervention group 250ml/min. Therapy is intended for a period of 72 hours (maximum defined by the manufacturer); with a 6-hour washout and, after that, the arm is changed to be exposed to the other blood flow."
Hospital Israelite Albert Einstein, São Paulo
Hospital Israelita Albert Einstein
OTHER